Showing results (1-10 of 11,255) with videos related to
Sort By:
Pageof 1,126
World Journal of Gastrointestinal Oncology|July 23, 2025
Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cellsMeng-Yan Chen, Chen Wang, Yu-Gang Wang, et al.World Journal of Clinical Oncology|September 3, 2025
Integrating tumor location into artificial intelligence-based prognostic models in cancerChen Wang, Meng-Yan Chen, Yu-Gang Wang, et al.World Journal of Hepatology|July 3, 2025
Future directions in prognostic modeling for dengue-induced severe hepatitisChen Wang, Hong Hu, Yun Song, et al.World Journal of Clinical Oncology|March 11, 2026
Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignanciesChen Wang, Jin Zhang, Zi-Ke Chen, et al.World Journal of Gastrointestinal Oncology|January 29, 2026
Gut microbiota and the colorectal cancer tumor microenvironment: From carcinogenic mechanisms to therapeutic opportunitiesZi-Ke Chen, Jia-Wei Zhao, Yu-Gang Wang, et al.Journal of Experimental & Clinical Cancer Research : CR|April 12, 2019
Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1Yu-Gang Wang, Tao Wang, Min Shi, et al.Journal of Cellular Physiology|September 15, 2018
LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axisYu-Gang Wang, Juan Liu, Min Shi, et al.World Journal of Hepatology|July 3, 2025
Long-term outcomes of early transjugular intrahepatic portosystemic shunts in patients with acute variceal bleeding and cirrhosisXin Tang, Ju-Bo Liang, Chen Wang, et al.Journal of Medical Genetics|December 7, 2018
T cell dysfunction in chronic hepatitis B infection and liver cancer: evidence from transcriptome analysisYu-Gang Wang, Dong-Hui Zheng, Min Shi, et al.Journal of Cellular Biochemistry|December 27, 2017
Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinomaMin Shi, Ye Jiang, Lu Yang, et al.Pageof 1,126